Physical Examination Components for Systemic Lupus Erythematosus
A comprehensive physical examination in SLE must systematically assess all major organ systems with particular focus on mucocutaneous, renal, neuropsychiatric, cardiovascular, and musculoskeletal manifestations, as these directly impact morbidity and mortality. 1
Essential Examination Components by Organ System
Mucocutaneous Assessment
Examine the skin thoroughly for lupus-specific lesions, which include:
- Acute cutaneous lupus (malar rash, photosensitive rash)
- Subacute cutaneous lupus (annular or papulosquamous lesions)
- Chronic cutaneous lupus (discoid lesions with scarring)
- Non-specific lesions (vasculitis, livedo reticularis, alopecia)
Document lesion activity versus damage using validated indices like CLASI when prominent cutaneous involvement exists 1. Oral and nasal ulcers should be specifically sought, as they may be painless and overlooked by patients.
Cardiovascular and Renal Examination
Measure blood pressure at every visit, as hypertension is both a manifestation of lupus nephritis and a predictor of poor renal outcomes 1. Elevated blood pressure combined with abnormal urinalysis demands urgent evaluation for nephritis.
Examine for:
- Peripheral edema (suggests nephrotic syndrome or heart failure)
- Cardiac murmurs (Libman-Sacks endocarditis)
- Pericardial friction rub (serositis)
- Signs of fluid overload
Neuropsychiatric Evaluation
Perform focused neurological examination including:
- Cognitive screening: Assess attention, concentration, memory, and word-finding through direct questioning about multitasking ability and household task completion 1
- Cranial nerve examination
- Motor strength and sensory testing (peripheral neuropathy)
- Gait assessment
- Mood and affect evaluation
The most frequent neuropsychiatric manifestations are headache, mood disorders, seizures, cognitive impairment, and cerebrovascular disease 1.
Musculoskeletal Examination
Assess all joints for:
- Synovitis (swelling, tenderness, warmth)
- Range of motion limitations
- Deformities (Jaccoud's arthropathy—reducible deformities without erosions)
- Muscle strength and tenderness (myositis)
Pulmonary Assessment
Examine for:
- Pleural effusions (dullness to percussion, decreased breath sounds)
- Pleuritic chest pain
- Interstitial lung disease (fine crackles)
Ophthalmologic Considerations
While not part of routine physical examination, baseline eye assessment is mandatory before initiating antimalarials, with annual follow-up after 5 years of treatment in low-risk patients, or yearly in high-risk patients (age >60, renal insufficiency, doses >6.5 mg/kg hydroxychloroquine) 1.
Critical Measurements
Vital Signs and Anthropometrics
- Blood pressure (every visit)
- Body mass index or waist circumference (cardiovascular risk assessment) 1
- Temperature (infection versus disease activity)
Disease Activity Assessment
Use a validated disease activity index at each visit (SLEDAI, BILAG, or similar) 1. This structured approach ensures systematic organ system review and quantifies disease burden.
Common Pitfalls to Avoid
Missing asymptomatic renal disease: Lupus nephritis can be clinically silent. Always check blood pressure and urinalysis even in asymptomatic patients 1.
Attributing elevated CRP solely to lupus: SLE patients typically have normal or minimally elevated CRP. Values >50 mg/L strongly suggest superimposed infection requiring urgent evaluation 1.
Overlooking cognitive impairment: Patients may not volunteer cognitive symptoms. Directly ask about problems with multitasking, memory, and concentration 1.
Inadequate skin examination: Examine sun-exposed areas, scalp (scarring alopecia), and mucous membranes. Discoid lesions can cause permanent scarring and disfigurement if untreated 1.
Frequency of Assessment
- Inactive disease without organ damage: Every 6-12 months 1
- Active disease or during immunosuppression changes: More frequent monitoring required
- Established nephropathy: At least every 3 months for first 2-3 years 1
The physical examination must be paired with appropriate laboratory monitoring (complete blood count, creatinine, urinalysis, complement levels, anti-dsDNA) to fully assess disease activity and guide treatment decisions 1.